NVST
What one share of Envista Holdings holds
Dental Equipment and Supplies
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology.
Envista Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-03; the balance sheet is as of 2026-07-03.
| Sales | $17.41 |
|---|---|
| Profit | $0.58 |
| Capex (buildings and equipment) | $0.33 |
| Free cash flow | $1.51 |
| Cash and investments | $7.01 |
| Debt | $8.94 |
| Book value | $19.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $21.98 | $2.35 | $0.38 | $2.43 | — | — |
| 2018 | $22.24 | $1.80 | $0.56 | $2.56 | — | — |
| 2019 | $16.75 | $1.60 | $0.57 | $2.34 | — | $22.31 |
| 2020 | $11.76 | $0.20 | $0.29 | $1.44 | — | $23.25 |
| 2021 | $14.13 | $1.92 | $0.31 | $1.73 | — | $25.11 |
| 2022 | $14.47 | $1.37 | $0.43 | $0.60 | — | $25.78 |
| 2023 | $15.38 | −$0.60 | $0.35 | $1.30 | — | $24.34 |
| 2024 | $14.58 | −$6.50 | $0.20 | $1.76 | — | $17.04 |
| 2025 | $16.07 | $0.28 | $0.27 | $1.36 | — | $18.96 |